Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Catabasis Pharma (CATB)

Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Catabasis Pharma 100 High Street Floor 28 Boston MA 02110 USA

www.catabasis.com P: 617-349-1971

Description:

Catabasis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of therapeutics for treatment of inflammatory, immunological and metabolic diseases. Its product development pipeline includes CAT-1004, CAT-2000 series including CAT-2054 and CAT-2003, CAT-4001 as well as various programs which are in different clinical-stage. Catabasis Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 33,337
Shares Outstanding, K 3,904
Annual Sales, $ 0 K
Annual Net Income, $ -37,300 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,470 K
60-Month Beta 1.66
% of Insider Shareholders 2.20%
Float, K 3,818
% Float 97.80%

Growth:

1-Year Return -78.17%
3-Year Return -81.27%
5-Year Return -96.43%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 95.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/09/21
Earnings Per Share ttm -12.84
EPS Growth vs. Prev Qtr -270.83%
EPS Growth vs. Prev Year -67.92%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 08/20/21

CATB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 1.41
Price/Earnings to Growth N/A
Return-on-Equity % -505.32%
Return-on-Assets % -33.30%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.00
Book Value/Share 9.52
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar